Reflections from Day 1 at the Women's Health Innovation Summit in Basel! After a day of thought-provoking discussions and valuable insights, it's clear: Women's health has long dwelled in the shadows of our healthcare discourse, but the time for change is now. Taking cues from the wisdom of Ida Tin, a trailblazer in the realm of Femtech, we are reminded of the profound significance of our mission. Our journey in women's health innovation is not merely about building products; it's about constructing a world where the unique healthcare needs of women are not just acknowledged, but prioritized. With last year's staggering $20 billion investment in Femtech, it's evident that the tide is turning, and the world is waking up to the untapped potential of this field. Joyce Harper illuminated the path forward, emphasizing the importance of evidence-based medicine and collaborative design processes. By engaging with diverse stakeholders and listening intently to the needs of our target audience, we have the power to co-create solutions that resonate deeply and drive meaningful change. Thomas Faustmann reinforced the cornerstone of trust and clinical rigor in our endeavors. In a landscape where credibility is paramount, establishing trust through robust clinical outcomes is our North Star. Drawing from Veronika Horvath's insights, we're reminded of the necessity to integrate our solutions seamlessly into existing healthcare landscapes. Understanding the nuances of different markets and ensuring compatibility are pivotal steps towards sustainable impact. Additionally, the revelations shared by Beatrice Lemberg and Angela Kerek shed light on the stark diagnostics gap and systemic gender bias in medical research. These sobering realities underscore the urgency of our collective mission and the imperative to dismantle barriers to inclusive healthcare. In the spirit of collaboration and collective action, it was a pleasure to network and engage in insightful conversations with so many passionate individuals today. Exploring potential synergies and forging new partnerships has only reaffirmed our commitment to drive positive change in women's health. We eagerly anticipate Day 2 of the summit, where we'll continue to learn, connect, and collaborate towards a brighter, more equitable future for women's health! #WHISEU #WomensHealth #Innovation #Femtech #Healthcare Women's Health Innovation Series
HEI Therapeutics
Produktion af medicinsk udstyr
Empowering patients with hypothyroidism to better manage their condition
Om os
HEI is a digital therapeutics company developing the world’s first medical-grade home monitoring solution for patients with hypothyroidism based on state-of-the-art microfluidics, microtechnology and artificial intelligence. Our solution is developed in close collaboration with patients and clinicians and empowers patients to better manage their condition and provides new digital opportunities to receive continuous care. More than 200 million people suffer from hypothyroidism globally and a large group of patients are undiagnosed or not properly medicated, leading to decreased quality of life, impaired job readiness, and elevated risks of comorbidities and mortality.
- Branche
- Produktion af medicinsk udstyr
- Virksomhedsstørrelse
- 2-10 medarbejdere
- Hovedkvarter
- København N
- Type
- Privat
Beliggenheder
-
Primær
Ole Maaløes Vej 3
C/O BioInnovation Institute
København N, 2200, DK
Medarbejdere hos HEI Therapeutics
Opdateringer
-
We are excited to announce that HEI Therapeutics will be participating in the upcoming Women's Health Innovation Summit Europe on April 16-17 in Basel, Switzerland. Our team, represented by Jesper Kimer, Winnie E. Svendsen, and Lisa Giesen, is eagerly anticipating this opportunity to engage with industry leaders, showcase our innovative solutions, and foster meaningful collaborations to advance women's health. We are committed to connecting with fellow attendees, gaining insights from thought-provoking discussions, and forming strategic partnerships to drive positive change in healthcare for women. See you there! #WHISEU #WomensHealth #Innovation #Femtech
-
"When you are diagnosed with hypothyroidism, you have to go to a doctor or endocrinologist for blood tests and consultations 8-10 times in the first year to get started on medication. This is resource-intensive and inefficient - today, more than 30% of patients are still poorly regulated after two years. This can be done better with home monitoring, as proven in other disease areas such as diabetes" -Jesper Kimer, Co-Founder and CEO of HEI Therapeutics https://lnkd.in/eVewRUss?
-
We want to take a moment to express our gratitude to Innovation Centre Denmark, Boston MassChallenge, and all collaborators involved in the SDG Landing Pad program. Your support has been instrumental in our journey to revolutionize healthcare with our innovative sensor technology. Through the SDG Landing Pad program, we've had the incredible opportunity to showcase our solution aimed at improving the lives of the millions affected by metabolic diseases worldwide. This collaboration has allowed us to gain traction in the American healthcare system and explore new avenues for growth and innovation. It perfectly aligns with our mission to make a meaningful impact on global health, and we are immensely grateful for the opportunity to be a part of it. Together, we're working towards a healthier, more sustainable future for all.
Meet the Danish medtech startup HEI Therapeutics 👋 With a new sensor technology, they are on a mission to make life easier for the approximately 250 million people who today suffer from metabolic diseases. Through Innovation Centre Denmark's project SDG Landing Pad, the Danish startup has now gained a foothold in the American healthcare system. Hear them talk about the whole journey in the video below Jesper Kimer Patrick Risager Mikkelsen Innovation Centre Denmark Boston MassChallenge BioInnovation Institute Watch the whole case video at https://lnkd.in/dk7KBtWW SDG Landing Pad was a collaboration between Innovation Centre Denmark, Danish Life Science Cluster, Clean , DigitalLead, Ministry of Higher Education and Science, Danish Ministry of Foreign Affairs and supported by Industriens Fond.